Actively Recruiting

Phase 3
Age: 18Years +
All Genders
NCT07043400

A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

Led by BeOne Medicines · Updated on 2026-05-11

351

Participants Needed

86

Research Sites

138 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study is designed to assess the levels of drug exposure following treatment with tislelizumab administered as a subcutaneous (SC) injection compared to intravenous infusion (IV) as first-line therapy in adults with gastric or gastroesophageal junction (GEJ) that is locally advanced and cannot be surgically removed or has spread from the stomach to other areas of the body. Approximately 351 patients will be participating in this study. The study is composed of a screening period, a treatment period, and a follow-up period.

CONDITIONS

Official Title

A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Histologically confirmed, locally advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma
  • No previous systemic therapy for locally advanced unresectable or metastatic gastric or GEJ cancer
  • At least 1 measurable or nonmeasurable lesion per RECIST v1.1 as assessed by investigator
  • Ability to provide tumor tissues for biomarker assessment
  • Eastern Cooperative Oncology Group (ECOG) Performance Status score of 0 or 1
  • Adequate organ function
  • Women of childbearing potential must agree to use highly effective birth control during the study and for at least 120 days after last dose of tislelizumab
  • Non-sterile males must agree to use highly effective birth control during the study and for at least 120 days after last dose of tislelizumab
Not Eligible

You will not qualify if you...

  • Squamous cell, undifferentiated, or other histological types of gastric cancer
  • Active leptomeningeal disease or uncontrolled brain metastasis (except stable, asymptomatic brain metastases without corticosteroids for at least 4 weeks before randomization)
  • Gastric or GEJ adenocarcinoma positive for human epidermal growth factor receptor 2 (HER2)
  • Active or history of autoimmune diseases that may relapse
  • Uncontrollable pleural effusion, pericardial effusion, or ascites requiring frequent drainage or diuretics within 7 days prior to randomization
  • Other protocol-defined inclusion and exclusion criteria may apply

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 86 locations

1

Ironwood Cancer and Research Centers

Chandler, Arizona, United States, 85224-5665

Actively Recruiting

2

Cancer and Blood Specialty Clinic

Los Alamitos, California, United States, 90720

Actively Recruiting

3

UC Health Cancer Care and Hematology Clinic Memorial Hospital Central

Colorado Springs, Colorado, United States, 80909

Actively Recruiting

4

Bioresearch Partners Holding Hialeah Hospital

Hialeah, Florida, United States, 33013-3804

Actively Recruiting

5

Orlando Health Ufhealth Cancer Center

Orlando, Florida, United States, 32806-2134

Actively Recruiting

6

Northwestern University

Chicago, Illinois, United States, 60611

Actively Recruiting

7

Hope and Healing Cancer Services

Hinsdale, Illinois, United States, 60521-0509

Actively Recruiting

8

University of Kansas Medical Center Research Institute

Kansas City, Kansas, United States, 66160-8500

Actively Recruiting

9

New England Cancer Specialists

Westbrook, Maine, United States, 04092

Actively Recruiting

10

St Louis Cancer Care, Llp

Bridgeton, Missouri, United States, 63044

Actively Recruiting

11

Nebraska Hematology Oncology

Lincoln, Nebraska, United States, 68506-7548

Actively Recruiting

12

Comprehensive Cancer Centers of Nevada

Las Vegas, Nevada, United States, 89169-3321

Actively Recruiting

13

Hunterdon Hematology Oncology

Flemington, New Jersey, United States, 08822-4603

Actively Recruiting

14

Summit Medical Group

Florham Park, New Jersey, United States, 07932-1049

Actively Recruiting

15

Oregon Oncology Specialists

Salem, Oregon, United States, 97301

Actively Recruiting

16

Md Anderson Cancer Center

Houston, Texas, United States, 77030-3907

Actively Recruiting

17

Scott and White Memorial Hospital

Temple, Texas, United States, 76508-0001

Actively Recruiting

18

Northwest Medical Specialties

Tacoma, Washington, United States, 98405

Actively Recruiting

19

Hospital Aleman

CABA, Argentina, 1425

Actively Recruiting

20

Krankenhaus Der Barmherzigen Schwestern Linz

Linz, Austria, 4010

Actively Recruiting

21

Medical Univeristy Vienna

Vienna, Austria, 1090

Actively Recruiting

22

Hospital de Amor Barretos

Barretos, Brazil, 14784-400

Actively Recruiting

23

CECAP

Blumenau, Brazil, 89035-510

Actively Recruiting

24

Hospital Brasilia

Brasília, Brazil, 71681-603

Actively Recruiting

25

Hospital Universiario Onofre Lopes

Natal, Brazil, 59012-300

Actively Recruiting

26

Hospital Sao Lucas Da Pucrs

Porto Alegre, Brazil, 90610-000

Actively Recruiting

27

IMIP

Recife, Brazil, 50070-902

Actively Recruiting

28

Inca Instituto Nacional de Cancer

Rio de Janeiro, Brazil, 20231-050

Actively Recruiting

29

Fundacao Faculdade Regional de Medicina de Sao Jose Do Rio Preto

São José do Rio Preto, Brazil, 15090-000

Actively Recruiting

30

Icesp Instituto Do Cancer Do Estado de Sao Paulo Octavio Frias de Oliveira

São Paulo, Brazil, 01246-000

Actively Recruiting

31

Instituto Dor de Pesquisa E Ensino Sao Paulo

São Paulo, Brazil, 01401-004

Actively Recruiting

32

Hospital Santa Rita de Cassia Afecc

Vitória, Brazil, 29043-260

Actively Recruiting

33

The Second Hospital of Anhui Medical University

Hefei, Anhui, China, 230601

Actively Recruiting

34

Cancer Hospital Chinese Academy of Medical Sciences

Beijing, Beijing Municipality, China, 100021

Actively Recruiting

35

The First Affiliated Hospital of Xiamen University

Xiamen, Fujian, China, 361003

Actively Recruiting

36

Anyang Tumor Hospital

Anyang, Henan, China, 455001

Actively Recruiting

37

Henan Cancer Hospital

Zhengzhou, Henan, China, 450000

Actively Recruiting

38

The First Affiliated Hospital of Zhengzhou University

Zhengzhou, Henan, China, 450052

Actively Recruiting

39

Nanjing Drum Tower Hospital,the Affiliated Hospital of Nanjing University Medical School

Nanjing, Jiangsu, China, 210008

Actively Recruiting

40

Ganzhou Peoples Hospital Ganzhou Hospital Affiliated to Nanchang University

Ganzhou, Jiangxi, China, 341000

Actively Recruiting

41

The First Hospital of China Medical University

Shenyang, Liaoning, China, 110001

Actively Recruiting

42

Shandong Cancer Hospital

Jinan, Shandong, China, 250117

Actively Recruiting

43

Affiliated Hospital of Jining Medical University

Jining, Shandong, China, 272000

Actively Recruiting

44

Changzhi Peoples Hospital

Changzhi, Shanxi, China, 046099

Actively Recruiting

45

Shanxi Provincial Cancer Hospital

Taiyuan, Shanxi, China, 030013

Actively Recruiting

46

Tianjin Medical University Cancer Institute and Hospital

Tianjin, Tianjin Municipality, China, 300060

Actively Recruiting

47

The First Affiliated Hospital of Wenzhou Medical University

Wenzhou, Zhejiang, China, 325000

Actively Recruiting

48

Masarykuv Onkologicky Ustav

Brno, Czechia, 602 00

Actively Recruiting

49

Fakultni Nemocnice Hradec Kralove

Hradec Králové, Czechia, 500 03

Actively Recruiting

50

Fakultni Nemocnice Olomouc

Olomouc, Czechia, 77900

Actively Recruiting

51

Vseobecna Fakultni Nemocnice V Praze

Prague, Czechia, 10000

Actively Recruiting

52

Institut Sainte Catherine

Avignon, France, 84000

Actively Recruiting

53

Chru de Brest Hopital Cavale Blanche

Brest, France, 29200

Actively Recruiting

54

Hopital Claude Huriez Chu Lille

Lille, France, 59000

Actively Recruiting

55

Irccs Azienda Ospedaliera Metropolitana (Aom)

Genova, Italy, 16132

Actively Recruiting

56

Fondazione Irccs Istituto Nazionale Dei Tumori

Milan, Italy, 20133

Actively Recruiting

57

Aou Pisana, Stabilimento Di Santa Chiara

Pisa, Italy, 56126

Actively Recruiting

58

Istituto Clinico Humanitas

Rozzano, Italy, 20089

Actively Recruiting

59

Matsuyama Red Cross Hospital

Matsuyama, Ehime, Japan, 790 8524

Actively Recruiting

60

Japan Community Health Care Organization Kyushu Hospital

Kitakyushu, Fukuoka, Japan, 806-0034

Actively Recruiting

61

Nho Hokkaido Cancer Center

Sapporo, Hokkaido, Japan, 003-0804

Actively Recruiting

62

Osaka Rosai Hospital

SakaiShi, Osaka, Japan, 591-8025

Actively Recruiting

63

Osaka Medical and Pharmaceutical University Hospital

Takatsukishi, Osaka, Japan, 569-8686

Actively Recruiting

64

Saitama Cancer Center

Kitaadachigun, Saitama, Japan, 362-0806

Actively Recruiting

65

Hamamatsu University School of Medicine, University Hospital

Hamamatsushi, Shizuoka, Japan, 431-3192

Actively Recruiting

66

Tochigi Cancer Center

Utsunomiya, Tochigi, Japan, 320-0834

Actively Recruiting

67

Institute of Science Tokyo Hospital

Bunkyoku, Tokyo, Japan, 113-8519

Actively Recruiting

68

Tokyo Metropolitan Bokutoh Hospital

SumidaKu, Tokyo, Japan, 130-8575

Actively Recruiting

69

Pratia McM Krakow

Krakow, Poland, 30-727

Actively Recruiting

70

Narodowy Instytut Onkologii Im Marii Sklodowskiej Curie Hematology Unit

Warsaw, Poland, 02-781

Actively Recruiting

71

Pan American Oncology Trials, Llc

Rio Piedras, Puerto Rico, 00935

Actively Recruiting

72

Seoul National University Bundang Hospital

Seongnam-si, Gyeonggi-do, South Korea, 13620

Active, Not Recruiting

73

Kyungpook National University Chilgok Hospital

BukGu, Gyeongsangbukdo, South Korea, 41404

Active, Not Recruiting

74

Samsung Medical Center

GangnamGu, Seoul Teugbyeolsi, South Korea, 06351

Active, Not Recruiting

75

Severance Hospital Yonsei University Health System

SeodaemunGu, Seoul Teugbyeolsi, South Korea, 03722

Active, Not Recruiting

76

Seoul National University Hospital

Seoul, Seoul Teugbyeolsi, South Korea, 03080

Active, Not Recruiting

77

Asan Medical Center

SongpaGu, Seoul Teugbyeolsi, South Korea, 05505

Active, Not Recruiting

78

Hospital Clinic de Barcelona

Barcelona, Spain, 08036

Actively Recruiting

79

Hospital Universitario de Navarra

Pamplona, Spain, 31008

Actively Recruiting

80

Hospital Clinico Universitario de Valencia

Valencia, Spain, 46010

Actively Recruiting

81

Hospital Universitario Miguel Servet

Zaragoza, Spain, 50009

Actively Recruiting

82

Medical Park Seyhan Hospital

Adana, Turkey (Türkiye), 01060

Actively Recruiting

83

Acibadem Adana Hospital

Kuruköprü, Turkey (Türkiye), 01060

Actively Recruiting

84

Cambridge University Hospitals Nhs Foundation Trust

Cambridge, United Kingdom, CB2 0QQ

Actively Recruiting

85

Ninewells Hospital and Medical School

Dundee, United Kingdom, DD1 9SY

Actively Recruiting

86

Clatterbridge Cancer Centre

Metropolitan Borough of Wirral, United Kingdom, CH63 4JY

Actively Recruiting

Loading map...

Research Team

B

BeOne Medicines

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma | DecenTrialz